Ipamorelin offers a way to push back against this decline
In the 8-week Phase II trial of tirzepatide, depressive symptoms will be evaluated in patients with obesity and alcohol use disorder (Morley, 2025, ID NCT07292519)
The EY-Parthenon analysis projects usage to grow quickly in the coming 10 years to between 13% and 21% of US adults, a total market size of 30 million to 50 million people
Data were normalized to the WT receptor
Green tea extract and EGCG Green tea extract, specifically its primary catechin EGCG (epigallocatechin gallate), has modest evidence for thermogenesis and fat oxidation
AARP Hearing Center Health Benefits of GLP-1s Beyond Weight Loss Popular medications like Ozempic and Wegovy can do more than just help shed pounds The famed quartet of diabetes and weight-loss drugs Ozempic, Wegovy, Zepbound and Mounjaro are well-known for their ability to help people shed pounds, in some cases up to 20 percent of body weight